Which of the following phases of pharmacokinetics is described as the removal of the drug or its metabolites through the kidneys, gastrointestinal tract, skin, or lungs?
Distribution
Metabolism
Absorption
Excretion
The Correct Answer is D
A. Distribution: This phase involves the transportation of the drug throughout the body after absorption, not removal.
B. Metabolism: This phase involves the chemical alteration of the drug in the body, often in the liver, not its removal.
C. Absorption: This phase involves the drug entering the bloodstream after administration.
D. Excretion: This is the phase where the drug or its metabolites are removed from the body through various routes such as the kidneys, gastrointestinal tract, skin, or lungs.
Nursing Test Bank
Naxlex Comprehensive Predictor Exams
Related Questions
Correct Answer is A
Explanation
A. NPH insulin is an intermediate-acting insulin that is administered via the subcutaneous route to manage blood sugar levels in clients with diabetes.
B. Regular insulin is a short-acting insulin that can be administered subcutaneously to control blood glucose levels in clients with type 2 diabetes.
C. This is an oral medication, not a parenteral (injected) medication. It is an oral sulfonylurea used to manage blood glucose in type 2 diabetes.
D. Metformin is also an oral medication used to treat type 2 diabetes and is not administered subcutaneously.
Correct Answer is B
Explanation
A. This is not the correct action because the issue with misoprostol in pregnancy is not related to the route of administration, but rather its potential to cause uterine contractions and harm to the pregnancy. The nurse should not administer the medication at all, regardless of the route, and should notify the physician for further clarification.
B. Misoprostol is contraindicated in pregnancy because it can cause uterine contractions, which may result in a miscarriage or preterm labor. The nurse should not administer this medication and must inform the healthcare provider to reconsider the prescription or explore alternative options to prevent stomach ulcers in pregnant clients.
C. Administering misoprostol to a pregnant client is dangerous, as it can stimulate uterine contractions and threaten the pregnancy. Monitoring for adverse reactions would not be an appropriate course of action, as the medication should not be given to begin with.
D. Even though verifying the patient's identity is always an important step, the main concern here is that misoprostol is contraindicated during pregnancy. The nurse should not administer this medication and must first clarify with the healthcare provider if it is suitable for the pregnant patient.
Whether you are a student looking to ace your exams or a practicing nurse seeking to enhance your expertise , our nursing education contents will empower you with the confidence and competence to make a difference in the lives of patients and become a respected leader in the healthcare field.
Visit Naxlex, invest in your future and unlock endless possibilities with our unparalleled nursing education contents today
Report Wrong Answer on the Current Question
Do you disagree with the answer? If yes, what is your expected answer? Explain.
Kindly be descriptive with the issue you are facing.